NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ObsEva SA (SW: OBSN)

 
OBSN Technical Analysis
5
As on 9th Jun 2023 OBSN STOCK Price closed @ 0.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.08 & Strong Sell for SHORT-TERM with Stoploss of 1.59 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

OBSNSTOCK Price

Open 0.06 Change Price %
High 0.06 1 Day 0.00 0.00
Low 0.06 1 Week -0.01 -14.29
Close 0.06 1 Month -0.02 -25.00
Volume 95916 1 Year -1.99 -97.07
52 Week High 2.13 | 52 Week Low 0.06
 
SW Switzerland Most Active Stocks
CSGN 0.81 0.00%
CSGN 0.81 0.00%
MBTN 0.58 1.75%
ABBN 34.50 0.76%
ABBN 34.50 0.76%
UBSG 18.20 -0.27%
UBSG 18.20 -0.27%
NOVN 90.17 -0.22%
NOVN 90.17 -0.22%
NESN 107.16 0.15%
 
SW Switzerland Top Gainers Stocks
PRFN 0.03 50.00%
PRFN 0.03 50.00%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
NEWN 0.94 17.50%
RLF 3.37 12.33%
RLF 3.37 12.33%
RLF 3.37 12.33%
RLF 3.37 12.33%
 
SW Switzerland Top Losers Stocks
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CADN 0.09 -10.00%
ADXN 0.11 -8.33%
 
 
OBSN
Daily Charts
OBSN
Intraday Charts
Whats New @
Bazaartrend
OBSN
Free Analysis
 
OBSN Important Levels Intraday
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
 
OBSN Forecast April 2024
4th UP Forecast2.2
3rd UP Forecast1.51
2nd UP Forecast1.09
1st UP Forecast0.66
1st DOWN Forecast-0.54
2nd DOWN Forecast-0.97
3rd DOWN Forecast-1.39
4th DOWN Forecast-2.08
 
OBSN Weekly Forecast
4th UP Forecast0.62
3rd UP Forecast0.44
2nd UP Forecast0.33
1st UP Forecast0.22
1st DOWN Forecast-0.10
2nd DOWN Forecast-0.21
3rd DOWN Forecast-0.32
4th DOWN Forecast-0.50
 
OBSN Forecast2024
4th UP Forecast4.45
3rd UP Forecast3.04
2nd UP Forecast2.17
1st UP Forecast1.3
1st DOWN Forecast-1.18
2nd DOWN Forecast-2.05
3rd DOWN Forecast-2.92
4th DOWN Forecast-4.33
 
 
OBSN Other Details
Segment EQ
Market Capital 194096496.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
OBSN Address
OBSN
 
OBSN Latest News
 
Your Comments and Response on ObsEva SA
 
OBSN Business Profile
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland. Address: Chemin des Aulx, 12, Geneva, Switzerland, 1228
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service